Emerging Cancer Molecular Diagnostic Tests

December 2011 | 45 pages | ID: C70D6A0C69AEN
Venture Planning Group

Abstracts

The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing molecular diagnostic technologies and products for cancer testing.

Contains 45 pages and 1 table

Contents

1. OVERVIEW

2. MAJOR CANCER TYPES

• Prostate
• Lung
• Colon and Rectum
• Breast
• Skin
• Uterine
• Leukemia
• Oral

3. ONCOGENES

• Abl/abl-bcr
• AIB1
• BRCA1
• CD44
• C-fos
• C-myb
• C-myc
• CYP17
• Erb-B
• HPC1
• N-myc
• P40
• P51
• P53
• PIK3CA
• PTI-1
• Ras
• Reg
• Sis
• Src

Table: Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests